Replimune Group, Inc. (REPL)
Recommendation: buy
PE: N/A
Previous close: 14.38
$14.19 USD
-1.32% change today
+173.94% change last 6 months
5D 1M 6M 1Y
Average analyst target: 16.5
Healthcare, Biotechnology
Market cap: 970.84MRecommendation: buy
PE: N/A
Previous close: 14.38
$14.19 USD
-1.32% change today
+173.94% change last 6 months
5D 1M 6M 1Y
Inversely correlated stocks:
MVF VTMX GFL More >>More data :
Price-to-book : 2.54Average analyst target: 16.5